clc3 Search Results


93
Alomone Labs anti clc-3
Anti Clc 3, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti clc-3/product/Alomone Labs
Average 93 stars, based on 1 article reviews
anti clc-3 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology clc3
Clc3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clc3/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
clc3 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

88
Santa Cruz Biotechnology sirna oligonucleotides against clc 3
Sirna Oligonucleotides Against Clc 3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sirna oligonucleotides against clc 3/product/Santa Cruz Biotechnology
Average 88 stars, based on 1 article reviews
sirna oligonucleotides against clc 3 - by Bioz Stars, 2026-02
88/100 stars
  Buy from Supplier

90
Alpha Diagnostics rabbit anti-rat clcn1
Rabbit Anti Rat Clcn1, supplied by Alpha Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-rat clcn1/product/Alpha Diagnostics
Average 90 stars, based on 1 article reviews
rabbit anti-rat clcn1 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
GenScript corporation tat-clc-3 107−116 (ygrkkrrqrrr-inskkkesaw
Tat Clc 3 107−116 (Ygrkkrrqrrr Inskkkesaw, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tat-clc-3 107−116 (ygrkkrrqrrr-inskkkesaw/product/GenScript corporation
Average 90 stars, based on 1 article reviews
tat-clc-3 107−116 (ygrkkrrqrrr-inskkkesaw - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma sirna clc-3
Sirna Clc 3, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sirna clc-3/product/Shanghai GenePharma
Average 90 stars, based on 1 article reviews
sirna clc-3 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Blackwell Science Ltd anti-clc-3 antibody
Anti Clc 3 Antibody, supplied by Blackwell Science Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-clc-3 antibody/product/Blackwell Science Ltd
Average 90 stars, based on 1 article reviews
anti-clc-3 antibody - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Institut Curie pmrfp-clc3
Pmrfp Clc3, supplied by Institut Curie, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pmrfp-clc3/product/Institut Curie
Average 90 stars, based on 1 article reviews
pmrfp-clc3 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
NeuroMab monoclonal antibody to clc-3
Monoclonal Antibody To Clc 3, supplied by NeuroMab, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal antibody to clc-3/product/NeuroMab
Average 90 stars, based on 1 article reviews
monoclonal antibody to clc-3 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
SunBio Inc adenovirus (ad)-clc-3 shrna
Effects of ClC-3 on Ang II-induced ROS production in HUVECs. a Ang II treatment increased ClC-3 expression in HUVECs (*P < 0.05 vs. CON. n = 5). b and c Effects of adenovirus (Ad)-ClC-3 shRNA and Ad-ClC-3 <t>transfection</t> on the expression of ClC-3 in HUVECs. Cells were transfected with Ad-ClC-3 shRNA (100 MOI) (b) or Ad-ClC-3 (100 MOI) (c) for 48 h (*P < 0.05 vs. CON. n = 4). d and e Representative images (× 400) with quantitative analysis of the dihydroethidium (DHE) fluorescence intensity (in arbitrary units) were shown in HUVECs transfected with Ad-ClC-3 shRNA (d) or Ad-ClC-3 (e) upon stimulation with Ang II (1 μmol/L) for 24 h. Ang II-induced ROS production was attenuated by knockdown of ClC-3, and further enhanced by ClC-3 overexpression (n = 6, **P < 0.01 vs. CON, ##P < 0.01 vs. Ang II). f ClC-3 potentiated Ang II-induced senescence of HUVECs. HUVECs were transfected with Ad-ClC-3 shRNA or Ad-ClC-3 for 48 h and then were incubated with or without Ang II (1 μmol/L) for 24 h. Representative photomicrographs (× 400) show the senescence-associated β-galactosidase (SA-β-Gal)-positive cells with different treatments (n = 6)
Adenovirus (Ad) Clc 3 Shrna, supplied by SunBio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adenovirus (ad)-clc-3 shrna/product/SunBio Inc
Average 90 stars, based on 1 article reviews
adenovirus (ad)-clc-3 shrna - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Forschungszentrum gmbh plasmid of mouse clc-3, splice variant c
Effects of ClC-3 on Ang II-induced ROS production in HUVECs. a Ang II treatment increased ClC-3 expression in HUVECs (*P < 0.05 vs. CON. n = 5). b and c Effects of adenovirus (Ad)-ClC-3 shRNA and Ad-ClC-3 <t>transfection</t> on the expression of ClC-3 in HUVECs. Cells were transfected with Ad-ClC-3 shRNA (100 MOI) (b) or Ad-ClC-3 (100 MOI) (c) for 48 h (*P < 0.05 vs. CON. n = 4). d and e Representative images (× 400) with quantitative analysis of the dihydroethidium (DHE) fluorescence intensity (in arbitrary units) were shown in HUVECs transfected with Ad-ClC-3 shRNA (d) or Ad-ClC-3 (e) upon stimulation with Ang II (1 μmol/L) for 24 h. Ang II-induced ROS production was attenuated by knockdown of ClC-3, and further enhanced by ClC-3 overexpression (n = 6, **P < 0.01 vs. CON, ##P < 0.01 vs. Ang II). f ClC-3 potentiated Ang II-induced senescence of HUVECs. HUVECs were transfected with Ad-ClC-3 shRNA or Ad-ClC-3 for 48 h and then were incubated with or without Ang II (1 μmol/L) for 24 h. Representative photomicrographs (× 400) show the senescence-associated β-galactosidase (SA-β-Gal)-positive cells with different treatments (n = 6)
Plasmid Of Mouse Clc 3, Splice Variant C, supplied by Forschungszentrum gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plasmid of mouse clc-3, splice variant c/product/Forschungszentrum gmbh
Average 90 stars, based on 1 article reviews
plasmid of mouse clc-3, splice variant c - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
GenScript corporation tat-clc-3 scr
Effects of ClC-3 on Ang II-induced ROS production in HUVECs. a Ang II treatment increased ClC-3 expression in HUVECs (*P < 0.05 vs. CON. n = 5). b and c Effects of adenovirus (Ad)-ClC-3 shRNA and Ad-ClC-3 <t>transfection</t> on the expression of ClC-3 in HUVECs. Cells were transfected with Ad-ClC-3 shRNA (100 MOI) (b) or Ad-ClC-3 (100 MOI) (c) for 48 h (*P < 0.05 vs. CON. n = 4). d and e Representative images (× 400) with quantitative analysis of the dihydroethidium (DHE) fluorescence intensity (in arbitrary units) were shown in HUVECs transfected with Ad-ClC-3 shRNA (d) or Ad-ClC-3 (e) upon stimulation with Ang II (1 μmol/L) for 24 h. Ang II-induced ROS production was attenuated by knockdown of ClC-3, and further enhanced by ClC-3 overexpression (n = 6, **P < 0.01 vs. CON, ##P < 0.01 vs. Ang II). f ClC-3 potentiated Ang II-induced senescence of HUVECs. HUVECs were transfected with Ad-ClC-3 shRNA or Ad-ClC-3 for 48 h and then were incubated with or without Ang II (1 μmol/L) for 24 h. Representative photomicrographs (× 400) show the senescence-associated β-galactosidase (SA-β-Gal)-positive cells with different treatments (n = 6)
Tat Clc 3 Scr, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tat-clc-3 scr/product/GenScript corporation
Average 90 stars, based on 1 article reviews
tat-clc-3 scr - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Effects of ClC-3 on Ang II-induced ROS production in HUVECs. a Ang II treatment increased ClC-3 expression in HUVECs (*P < 0.05 vs. CON. n = 5). b and c Effects of adenovirus (Ad)-ClC-3 shRNA and Ad-ClC-3 transfection on the expression of ClC-3 in HUVECs. Cells were transfected with Ad-ClC-3 shRNA (100 MOI) (b) or Ad-ClC-3 (100 MOI) (c) for 48 h (*P < 0.05 vs. CON. n = 4). d and e Representative images (× 400) with quantitative analysis of the dihydroethidium (DHE) fluorescence intensity (in arbitrary units) were shown in HUVECs transfected with Ad-ClC-3 shRNA (d) or Ad-ClC-3 (e) upon stimulation with Ang II (1 μmol/L) for 24 h. Ang II-induced ROS production was attenuated by knockdown of ClC-3, and further enhanced by ClC-3 overexpression (n = 6, **P < 0.01 vs. CON, ##P < 0.01 vs. Ang II). f ClC-3 potentiated Ang II-induced senescence of HUVECs. HUVECs were transfected with Ad-ClC-3 shRNA or Ad-ClC-3 for 48 h and then were incubated with or without Ang II (1 μmol/L) for 24 h. Representative photomicrographs (× 400) show the senescence-associated β-galactosidase (SA-β-Gal)-positive cells with different treatments (n = 6)

Journal: Acta Pharmacologica Sinica

Article Title: ClC-3 promotes angiotensin II-induced reactive oxygen species production in endothelial cells by facilitating Nox2 NADPH oxidase complex formation

doi: 10.1038/s41401-018-0072-0

Figure Lengend Snippet: Effects of ClC-3 on Ang II-induced ROS production in HUVECs. a Ang II treatment increased ClC-3 expression in HUVECs (*P < 0.05 vs. CON. n = 5). b and c Effects of adenovirus (Ad)-ClC-3 shRNA and Ad-ClC-3 transfection on the expression of ClC-3 in HUVECs. Cells were transfected with Ad-ClC-3 shRNA (100 MOI) (b) or Ad-ClC-3 (100 MOI) (c) for 48 h (*P < 0.05 vs. CON. n = 4). d and e Representative images (× 400) with quantitative analysis of the dihydroethidium (DHE) fluorescence intensity (in arbitrary units) were shown in HUVECs transfected with Ad-ClC-3 shRNA (d) or Ad-ClC-3 (e) upon stimulation with Ang II (1 μmol/L) for 24 h. Ang II-induced ROS production was attenuated by knockdown of ClC-3, and further enhanced by ClC-3 overexpression (n = 6, **P < 0.01 vs. CON, ##P < 0.01 vs. Ang II). f ClC-3 potentiated Ang II-induced senescence of HUVECs. HUVECs were transfected with Ad-ClC-3 shRNA or Ad-ClC-3 for 48 h and then were incubated with or without Ang II (1 μmol/L) for 24 h. Representative photomicrographs (× 400) show the senescence-associated β-galactosidase (SA-β-Gal)-positive cells with different treatments (n = 6)

Article Snippet: Adenovirus transfection Adenovirus (Ad)-ClC-3 shRNA and Ad-ClC-3 cDNA were designed and produced by Sunbio Medical Biotechnology (Shanghai, China).

Techniques: Expressing, shRNA, Transfection, Fluorescence, Knockdown, Over Expression, Incubation

ClC-3 increased p47phox phosphorylation through p38 MAPK pathway. a The time course of p47phox and p38 MAPK phosphorylation in Ang II-treated HUVECs (n = 5, *P < 0.05 vs. CON, **P < 0.01 vs. CON). b Knockdown of ClC-3 decreased p38 MAPK phosphorylation induced by Ang II (1 μmol/L) treatment for 30 min. c Overexpression of ClC-3 enhanced p38 MAPK phosphorylation (n = 5, *P < 0.05 vs. CON, #P < 0.05 vs. Ang II). d–f Cells were pretreated with the p38 MAPK inhibitor SB203580 (10 μmol/L) for 6 h before Ad-ClC-3 transfection. SB203580 abolished the increase in p47phox phosphorylation (d), NADPH oxidase activity (e), and ROS generation (f) induced by ClC-3 overexpression in HUVECs with Ang II treatment, respectively (n = 6, **P < 0.01 vs. Ang II, ##P < 0.01 vs. Ang II+Ad-ClC-3)

Journal: Acta Pharmacologica Sinica

Article Title: ClC-3 promotes angiotensin II-induced reactive oxygen species production in endothelial cells by facilitating Nox2 NADPH oxidase complex formation

doi: 10.1038/s41401-018-0072-0

Figure Lengend Snippet: ClC-3 increased p47phox phosphorylation through p38 MAPK pathway. a The time course of p47phox and p38 MAPK phosphorylation in Ang II-treated HUVECs (n = 5, *P < 0.05 vs. CON, **P < 0.01 vs. CON). b Knockdown of ClC-3 decreased p38 MAPK phosphorylation induced by Ang II (1 μmol/L) treatment for 30 min. c Overexpression of ClC-3 enhanced p38 MAPK phosphorylation (n = 5, *P < 0.05 vs. CON, #P < 0.05 vs. Ang II). d–f Cells were pretreated with the p38 MAPK inhibitor SB203580 (10 μmol/L) for 6 h before Ad-ClC-3 transfection. SB203580 abolished the increase in p47phox phosphorylation (d), NADPH oxidase activity (e), and ROS generation (f) induced by ClC-3 overexpression in HUVECs with Ang II treatment, respectively (n = 6, **P < 0.01 vs. Ang II, ##P < 0.01 vs. Ang II+Ad-ClC-3)

Article Snippet: Adenovirus transfection Adenovirus (Ad)-ClC-3 shRNA and Ad-ClC-3 cDNA were designed and produced by Sunbio Medical Biotechnology (Shanghai, China).

Techniques: Phospho-proteomics, Knockdown, Over Expression, Transfection, Activity Assay